Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more
Athens Medical C.S.A. (IATR) - Total Assets
Latest total assets as of June 2025: €526.18 Million EUR
Based on the latest financial reports, Athens Medical C.S.A. (IATR) holds total assets worth €526.18 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Athens Medical C.S.A. - Total Assets Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Athens Medical C.S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Athens Medical C.S.A.'s total assets of €526.18 Million consist of 38.7% current assets and 61.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.5% |
| Accounts Receivable | €122.43 Million | 24.7% |
| Inventory | €7.21 Million | 1.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.21 Million | 1.3% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Athens Medical C.S.A.'s current assets represent 38.7% of total assets in 2024, an increase from 34.1% in 2014.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, up from 1.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 24.7% of total assets.
Athens Medical C.S.A. Competitors by Total Assets
Key competitors of Athens Medical C.S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Athens Medical C.S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Athens Medical C.S.A. generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Athens Medical C.S.A. generates $ 0.36 in net profit.
Athens Medical C.S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 0.91 | 0.81 |
| Quick Ratio | 0.79 | 0.88 | 0.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-49.97 Million | € -20.59 Million | € -27.28 Million |
Athens Medical C.S.A. - Advanced Valuation Insights
This section examines the relationship between Athens Medical C.S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | €495.86 Million |
| Market Capitalization | $85.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Athens Medical C.S.A.'s assets below their book value (0.17 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Athens Medical C.S.A.'s assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Athens Medical C.S.A. (2014–2024)
The table below shows the annual total assets of Athens Medical C.S.A. from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €495.86 Million | +3.88% |
| 2023-12-31 | €477.34 Million | +14.17% |
| 2022-12-31 | €418.09 Million | -1.10% |
| 2021-12-31 | €422.76 Million | +1.01% |
| 2020-12-31 | €418.54 Million | +13.70% |
| 2019-12-31 | €368.11 Million | +2.41% |
| 2018-12-31 | €359.46 Million | -0.55% |
| 2017-12-31 | €361.46 Million | -1.95% |
| 2016-12-31 | €368.66 Million | -0.43% |
| 2015-12-31 | €370.24 Million | -2.76% |
| 2014-12-31 | €380.74 Million | -- |